Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) To Present New Data On Brexpiprazole In Major Depression (MDD) At European Congress Of Psychiatry (EPA)
1/24/2014 9:26:43 AM
Valby, Denmark and Tokyo, Japan, 24 January 2014 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the first top-line phase III trial data on the investigational compound brexpiprazole will be presented at the 22nd European Psychiatry Association Congress (EPA) in Munich, Germany on 2 March, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by